Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.158
-0.031 (-16.19%)
May 3, 2024, 3:41 PM EDT - Market closed

PLSH Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
0.10.010.020.080.0200.161.060
Short-Term Investments
0.011.113.792.851.430000
Cash & Cash Equivalents
0.121.113.812.940.0200.161.060
Cash Growth
-89.60%-70.76%29.73%15862.05%839.03%-98.78%-84.72%--
Receivables
0.260.710.740.150.20000
Inventory
4.014.454.268.411.340000
Other Current Assets
0.260.110.280.03-0.560.010.011.020.08
Total Current Assets
4.666.389.111.522.430.010.172.080.08
Property, Plant & Equipment
10.3110.9212.4417.530.870000
Goodwill
3.012.192.192.192.190000
Intangible Assets
000.060.120.18000.050
Other Long-Term Assets
00002.350000
Total Long-Term Assets
13.3313.1114.6919.845.59000.050.01
Total Assets
17.9819.4923.7831.368.020.010.172.130.08
Accounts Payable
4.282.671.692.031.90.920.740.570.08
Deferred Revenue
0.35-12.98-1.69-2.030.220000
Current Debt
14.8212.418.3916.50.310.49000
Other Current Liabilities
012.981.691.771.391.921.650.060.1
Total Current Liabilities
19.4515.0710.0718.263.813.342.390.620.18
Long-Term Debt
3.576.566.616.390.10.1000
Other Long-Term Liabilities
3.250000.220000
Total Long-Term Liabilities
6.836.566.616.390.320.1000
Total Liabilities
26.2721.6316.6824.654.133.442.390.620.18
Total Debt
21.6518.971522.890.630.59000
Debt Growth
14.12%26.49%-34.48%3520.00%6.84%----
Common Stock
000000000
Retained Earnings
-33.92-25.91-16.77-11.98-20.92-10.54-6.2-2.34-0.74
Comprehensive Income
-00-0-0.1300-0-00
Shareholders' Equity
-8.29-2.147.16.714.43-3.42-2.221.5-0.09
Total Liabilities and Equity
17.9819.4923.7831.368.020.010.172.130.08
Net Cash / Debt
-21.53-17.85-11.18-19.950.81-0.590.161.060
Net Cash / Debt Growth
-------84.72%--
Net Cash Per Share
-1.29-1.20-0.63-1.180.67-0.120.000.05-
Working Capital
-14.79-8.69-0.97-6.74-1.38-3.32-2.221.45-0.1
Book Value Per Share
-0.50-0.140.400.403.65-0.72-0.070.08-0.01
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.